Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Liu, HD"" wg kryterium: Autor


Wyświetlanie 1-1 z 1
Tytuł:
Acute patient-reported outcomes in B-cell malignancies treated with axicabtagene ciloleucel.
Autorzy:
Hoogland AI; Moffitt Cancer Center, Department of Health Outcomes and Behavior, Tampa, FL, USA.
Jayani RV; Vanderbilt University Medical Center, Department of Medicine, Division of Hematology/Oncology, Nashville, TN, USA.
Collier A; Moffitt Cancer Center, Department of Health Outcomes and Behavior, Tampa, FL, USA.
Irizarry-Arroyo N; Moffitt Cancer Center, Department of Health Outcomes and Behavior, Tampa, FL, USA.
Rodriguez Y; Moffitt Cancer Center, Department of Health Outcomes and Behavior, Tampa, FL, USA.
Jain MD; Moffitt Cancer Center, Department of Blood and Marrow Transplant and Cellular Immunotherapy, Tampa, FL, USA.
Booth-Jones M; Moffitt Cancer Center, Department of Supportive Care Medicine, Tampa, FL, USA.
Hyland KA; Moffitt Cancer Center, Department of Health Outcomes and Behavior, Tampa, FL, USA.
James BW; Moffitt Cancer Center, Department of Health Outcomes and Behavior, Tampa, FL, USA.
Barata A; Moffitt Cancer Center, Department of Health Outcomes and Behavior, Tampa, FL, USA.
Bachmeier CA; Moffitt Cancer Center, Department of Blood and Marrow Transplant and Cellular Immunotherapy, Tampa, FL, USA.
Chavez JC; Moffitt Cancer Center, Department of Malignant Hematology, Tampa, FL, USA.
Khimani F; Moffitt Cancer Center, Department of Blood and Marrow Transplant and Cellular Immunotherapy, Tampa, FL, USA.
Krivenko GS; Moffitt Cancer Center, Department of Blood and Marrow Transplant and Cellular Immunotherapy, Tampa, FL, USA.
Lazaryan A; Moffitt Cancer Center, Department of Blood and Marrow Transplant and Cellular Immunotherapy, Tampa, FL, USA.
Liu HD; Moffitt Cancer Center, Department of Blood and Marrow Transplant and Cellular Immunotherapy, Tampa, FL, USA.
Nishihori T; Moffitt Cancer Center, Department of Blood and Marrow Transplant and Cellular Immunotherapy, Tampa, FL, USA.
Pinilla-Ibarz J; Moffitt Cancer Center, Department of Malignant Hematology, Tampa, FL, USA.
Shah BD; Moffitt Cancer Center, Department of Malignant Hematology, Tampa, FL, USA.
Abidi M; Spectrum Health Cancer Center, Michigan State University, Grand Rapids, MI, USA.
Locke FL; Moffitt Cancer Center, Department of Blood and Marrow Transplant and Cellular Immunotherapy, Tampa, FL, USA.
Jim HSL; Moffitt Cancer Center, Department of Health Outcomes and Behavior, Tampa, FL, USA.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2021 Mar; Vol. 10 (6), pp. 1936-1943. Date of Electronic Publication: 2021 Feb 28.
Typ publikacji:
Journal Article; Observational Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Patient Reported Outcome Measures*
Quality of Life*
Antigens, CD19/*therapeutic use
Immunotherapy, Adoptive/*adverse effects
Lymphoma, Large B-Cell, Diffuse/*therapy
Antigens, CD19/adverse effects ; Anxiety/chemically induced ; Attention/drug effects ; Biological Products ; Diarrhea/chemically induced ; Fatigue/chemically induced ; Feeding and Eating Disorders/chemically induced ; Female ; Humans ; Male ; Middle Aged ; Pain/chemically induced ; Physical Functional Performance ; Time Factors ; Xerostomia/chemically induced
Czasopismo naukowe
    Wyświetlanie 1-1 z 1

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies